1 Anti-tumor Drug Market Overview 1.1 Product Overview and Scope of Anti-tumor Drug 1.2 Classification of Anti-tumor Drug by Type 1.2.1 Global Anti-tumor Drug Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Global Anti-tumor Drug Revenue Market Share by Type in 2019 1.2.3 Cytotoxic Drugs 1.2.4 Non-cytotoxic Drugs 1.3 Global Anti-tumor Drug Market by Application 1.3.1 Overview: Global Anti-tumor Drug Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Alkylating Agents 1.3.3 Anti-metabolism Drugs 1.3.4 Platinum Antineoplastic Agents 1.3.5 Anthracycline antitumor drugs 1.3.6 Microtubule Stabilizer 1.3.7 Endocrine Therapy Drugs 1.3.8 Immunotherapy Drugs 1.3.9 Gene Therapy Drugs 1.3.10 Targeted Antineoplastic Drugs 1.4 Global Anti-tumor Drug Market by Regions 1.4.1 Global Anti-tumor Drug Market Size by Regions: 2015 VS 2019 VS 2025 1.4.2 Global Market Size of Anti-tumor Drug (2015-2025) 1.4.3 North America (USA, Canada and Mexico) Anti-tumor Drug Status and Prospect (2015-2025) 1.4.4 Europe (Germany, France, UK, Russia and Italy) Anti-tumor Drug Status and Prospect (2015-2025) 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anti-tumor Drug Status and Prospect (2015-2025) 1.4.6 South America (Brazil, Argentina, Colombia) Anti-tumor Drug Status and Prospect (2015-2025) 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anti-tumor Drug Status and Prospect (2015-2025) 1.5 COVID-19 Outbreak: Anti-tumor Drug Industry Impact 1.5.1 COVID-19 Potential Implications for the Anti-tumor Drug 1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Anti-tumor Drug 1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April 1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4 1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2 1.5.2 Opportunity Analysis in Covid-19 Crisis 1.5.3 Market Risk and Restraints 1.5.4 Market Driving Force 2 Company Profiles 2.1 Roche 2.1.1 Roche Details 2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 Roche SWOT Analysis 2.1.4 Roche Product and Services 2.1.5 Roche Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.2 Takeda 2.2.1 Takeda Details 2.2.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 Takeda SWOT Analysis 2.2.4 Takeda Product and Services 2.2.5 Takeda Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.3 Bristol-Myers Squibb 2.3.1 Bristol-Myers Squibb Details 2.3.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 Bristol-Myers Squibb SWOT Analysis 2.3.4 Bristol-Myers Squibb Product and Services 2.3.5 Bristol-Myers Squibb Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.4 Novartis 2.4.1 Novartis Details 2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 Novartis SWOT Analysis 2.4.4 Novartis Product and Services 2.4.5 Novartis Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.5 Pfizer 2.5.1 Pfizer Details 2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 Pfizer SWOT Analysis 2.5.4 Pfizer Product and Services 2.5.5 Pfizer Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.6 Celgene 2.6.1 Celgene Details 2.6.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis 2.6.3 Celgene SWOT Analysis 2.6.4 Celgene Product and Services 2.6.5 Celgene Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.7 AstraZeneca 2.7.1 AstraZeneca Details 2.7.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis 2.7.3 AstraZeneca SWOT Analysis 2.7.4 AstraZeneca Product and Services 2.7.5 AstraZeneca Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.8 Johnson & Johnson 2.8.1 Johnson & Johnson Details 2.8.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis 2.8.3 Johnson & Johnson SWOT Analysis 2.8.4 Johnson & Johnson Product and Services 2.8.5 Johnson & Johnson Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.9 Amgen 2.9.1 Amgen Details 2.9.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis 2.9.3 Amgen SWOT Analysis 2.9.4 Amgen Product and Services 2.9.5 Amgen Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.10 Eli Lilly 2.10.1 Eli Lilly Details 2.10.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis 2.10.3 Eli Lilly SWOT Analysis 2.10.4 Eli Lilly Product and Services 2.10.5 Eli Lilly Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.11 Biogen Idec 2.11.1 Biogen Idec Details 2.11.2 Biogen Idec Major Business and Total Revenue (Financial Highlights) Analysis 2.11.3 Biogen Idec SWOT Analysis 2.11.4 Biogen Idec Product and Services 2.11.5 Biogen Idec Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.12 Otsuka 2.12.1 Otsuka Details 2.12.2 Otsuka Major Business and Total Revenue (Financial Highlights) Analysis 2.12.3 Otsuka SWOT Analysis 2.12.4 Otsuka Product and Services 2.12.5 Otsuka Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.13 Astellas 2.13.1 Astellas Details 2.13.2 Astellas Major Business and Total Revenue (Financial Highlights) Analysis 2.13.3 Astellas SWOT Analysis 2.13.4 Astellas Product and Services 2.13.5 Astellas Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.14 Eisai 2.14.1 Eisai Details 2.14.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis 2.14.3 Eisai SWOT Analysis 2.14.4 Eisai Product and Services 2.14.5 Eisai Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.15 Bayer 2.15.1 Bayer Details 2.15.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis 2.15.3 Bayer SWOT Analysis 2.15.4 Bayer Product and Services 2.15.5 Bayer Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.16 Merck & Co 2.16.1 Merck & Co Details 2.16.2 Merck & Co Major Business and Total Revenue (Financial Highlights) Analysis 2.16.3 Merck & Co SWOT Analysis 2.16.4 Merck & Co Product and Services 2.16.5 Merck & Co Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.17 Teva 2.17.1 Teva Details 2.17.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis 2.17.3 Teva SWOT Analysis 2.17.4 Teva Product and Services 2.17.5 Teva Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 2.18 Sanofi 2.18.1 Sanofi Details 2.18.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis 2.18.3 Sanofi SWOT Analysis 2.18.4 Sanofi Product and Services 2.18.3 Sanofi Anti-tumor Drug Revenue, Gross Margin and Market Share (2018-2019) 3 Market Competition, by Players 3.1 Global Anti-tumor Drug Revenue and Share by Players (2015-2020) 3.2 Market Concentration Rate 3.2.1 Top 5 Anti-tumor Drug Players Market Share 3.2.2 Top 10 Anti-tumor Drug Players Market Share 3.3 Market Competition Trend 4 Market Size by Regions 4.1 Global Anti-tumor Drug Revenue and Market Share by Regions 4.2 North America Anti-tumor Drug Revenue and Growth Rate (2015-2020) 4.3 Europe Anti-tumor Drug Revenue and Growth Rate (2015-2020) 4.4 Asia-Pacific Anti-tumor Drug Revenue and Growth Rate (2015-2020) 4.5 South America Anti-tumor Drug Revenue and Growth Rate (2015-2020) 4.6 Middle East & Africa Anti-tumor Drug Revenue and Growth Rate (2015-2020) 5 North America Anti-tumor Drug Revenue by Countries 5.1 North America Anti-tumor Drug Revenue by Countries (2015-2020) 5.2 USA Anti-tumor Drug Revenue and Growth Rate (2015-2020) 5.3 Canada Anti-tumor Drug Revenue and Growth Rate (2015-2020) 5.4 Mexico Anti-tumor Drug Revenue and Growth Rate (2015-2020) 6 Europe Anti-tumor Drug Revenue by Countries 6.1 Europe Anti-tumor Drug Revenue by Countries (2015-2020) 6.2 Germany Anti-tumor Drug Revenue and Growth Rate (2015-2020) 6.3 UK Anti-tumor Drug Revenue and Growth Rate (2015-2020) 6.4 France Anti-tumor Drug Revenue and Growth Rate (2015-2020) 6.5 Russia Anti-tumor Drug Revenue and Growth Rate (2015-2020) 6.6 Italy Anti-tumor Drug Revenue and Growth Rate (2015-2020) 7 Asia-Pacific Anti-tumor Drug Revenue by Countries 7.1 Asia-Pacific Anti-tumor Drug Revenue by Countries (2015-2020) 7.2 China Anti-tumor Drug Revenue and Growth Rate (2015-2020) 7.3 Japan Anti-tumor Drug Revenue and Growth Rate (2015-2020) 7.4 Korea Anti-tumor Drug Revenue and Growth Rate (2015-2020) 7.5 India Anti-tumor Drug Revenue and Growth Rate (2015-2020) 7.6 Southeast Asia Anti-tumor Drug Revenue and Growth Rate (2015-2020) 8 South America Anti-tumor Drug Revenue by Countries 8.1 South America Anti-tumor Drug Revenue by Countries (2015-2020) 8.2 Brazil Anti-tumor Drug Revenue and Growth Rate (2015-2020) 8.3 Argentina Anti-tumor Drug Revenue and Growth Rate (2015-2020) 9 Middle East & Africa Revenue Anti-tumor Drug by Countries 9.1 Middle East & Africa Anti-tumor Drug Revenue by Countries (2015-2020) 9.2 Saudi Arabia Anti-tumor Drug Revenue and Growth Rate (2015-2020) 9.3 UAE Anti-tumor Drug Revenue and Growth Rate (2015-2020) 9.4 Egypt Anti-tumor Drug Revenue and Growth Rate (2015-2020) 9.5 South Africa Anti-tumor Drug Revenue and Growth Rate (2015-2020) 10 Market Size Segment by Type 10.1 Global Anti-tumor Drug Revenue and Market Share by Type (2015-2020) 10.2 Global Anti-tumor Drug Market Forecast by Type (2019-2024) 10.3 Cytotoxic Drugs Revenue Growth Rate (2015-2025) 10.4 Non-cytotoxic Drugs Revenue Growth Rate (2015-2025) 11 Global Anti-tumor Drug Market Segment by Application 11.1 Global Anti-tumor Drug Revenue Market Share by Application (2015-2020) 11.2 Anti-tumor Drug Market Forecast by Application (2019-2024) 11.3 Alkylating Agents Revenue Growth (2015-2020) 11.4 Anti-metabolism Drugs Revenue Growth (2015-2020) 11.5 Platinum Antineoplastic Agents Revenue Growth (2015-2020) 11.6 Anthracycline antitumor drugs Revenue Growth (2015-2020) 11.7 Microtubule Stabilizer Revenue Growth (2015-2020) 11.8 Endocrine Therapy Drugs Revenue Growth (2015-2020) 11.9 Immunotherapy Drugs Revenue Growth (2015-2020) 11.10 Gene Therapy Drugs Revenue Growth (2015-2020) 11.11 Targeted Antineoplastic Drugs Revenue Growth (2015-2020) 12 Global Anti-tumor Drug Market Size Forecast (2021-2025) 12.1 Global Anti-tumor Drug Market Size Forecast (2021-2025) 12.2 Global Anti-tumor Drug Market Forecast by Regions (2021-2025) 12.3 North America Anti-tumor Drug Revenue Market Forecast (2021-2025) 12.4 Europe Anti-tumor Drug Revenue Market Forecast (2021-2025) 12.5 Asia-Pacific Anti-tumor Drug Revenue Market Forecast (2021-2025) 12.6 South America Anti-tumor Drug Revenue Market Forecast (2021-2025) 12.7 Middle East & Africa Anti-tumor Drug Revenue Market Forecast (2021-2025) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source 14.3 Disclaimer 14.4 About US

List of Tables Table 1. Global Anti-tumor Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Anti-tumor Drug by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Anti-tumor Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Global Market Anti-tumor Drug Revenue (Million USD) Comparison by Regions 2015-2025 Table 5. Global Anti-tumor Drug Market Size and Growth Estimation in Various Scenarios in 2020 Table 6. Roche Corporate Information, Location and Competitors Table 7. Roche Anti-tumor Drug Major Business Table 8. Roche Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 9. Roche SWOT Analysis Table 10. Roche Anti-tumor Drug Product and Solutions Table 11. Roche Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 12. Takeda Corporate Information, Location and Competitors Table 13. Takeda Anti-tumor Drug Major Business Table 14. Takeda Anti-tumor Drug Total Revenue (USD Million) (2018-2019) Table 15. Takeda SWOT Analysis Table 16. Takeda Anti-tumor Drug Product and Solutions Table 17. Takeda Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 18. Bristol-Myers Squibb Corporate Information, Location and Competitors Table 19. Bristol-Myers Squibb Anti-tumor Drug Major Business Table 20. Bristol-Myers Squibb Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 21. Bristol-Myers Squibb SWOT Analysis Table 22. Bristol-Myers Squibb Anti-tumor Drug Product and Solutions Table 23. Bristol-Myers Squibb Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 24. Novartis Corporate Information, Location and Competitors Table 25. Novartis Anti-tumor Drug Major Business Table 26. Novartis Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 27. Novartis SWOT Analysis Table 28. Novartis Anti-tumor Drug Product and Solutions Table 29. Novartis Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 30. Pfizer Corporate Information, Location and Competitors Table 31. Pfizer Anti-tumor Drug Major Business Table 32. Pfizer Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 33. Pfizer SWOT Analysis Table 34. Pfizer Anti-tumor Drug Product and Solutions Table 35. Pfizer Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 36. Celgene Corporate Information, Location and Competitors Table 37. Celgene Anti-tumor Drug Major Business Table 38. Celgene Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 39. Celgene SWOT Analysis Table 40. Celgene Anti-tumor Drug Product and Solutions Table 41. Celgene Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 42. AstraZeneca Corporate Information, Location and Competitors Table 43. AstraZeneca Anti-tumor Drug Major Business Table 44. AstraZeneca Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 45. AstraZeneca SWOT Analysis Table 46. AstraZeneca Anti-tumor Drug Product and Solutions Table 47. AstraZeneca Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 48. Johnson & Johnson Corporate Information, Location and Competitors Table 49. Johnson & Johnson Anti-tumor Drug Major Business Table 50. Johnson & Johnson Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 51. Johnson & Johnson SWOT Analysis Table 52. Johnson & Johnson Anti-tumor Drug Product and Solutions Table 53. Johnson & Johnson Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 54. Amgen Corporate Information, Location and Competitors Table 55. Amgen Anti-tumor Drug Major Business Table 56. Amgen Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 57. Amgen SWOT Analysis Table 58. Amgen Anti-tumor Drug Product and Solutions Table 59. Amgen Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 60. Eli Lilly Corporate Information, Location and Competitors Table 61. Eli Lilly Anti-tumor Drug Major Business Table 62. Eli Lilly Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 63. Eli Lilly SWOT Analysis Table 64. Eli Lilly Anti-tumor Drug Product and Solutions Table 65. Eli Lilly Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 66. Biogen Idec Corporate Information, Location and Competitors Table 67. Biogen Idec Anti-tumor Drug Major Business Table 68. Biogen Idec Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 69. Biogen Idec SWOT Analysis Table 70. Biogen Idec Anti-tumor Drug Product and Solutions Table 71. Biogen Idec Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 72. Otsuka Corporate Information, Location and Competitors Table 73. Otsuka Anti-tumor Drug Major Business Table 74. Otsuka Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 75. Otsuka SWOT Analysis Table 76. Otsuka Anti-tumor Drug Product and Solutions Table 77. Otsuka Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 78. Astellas Corporate Information, Location and Competitors Table 79. Astellas Anti-tumor Drug Major Business Table 80. Astellas Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 81. Astellas SWOT Analysis Table 82. Astellas Anti-tumor Drug Product and Solutions Table 83. Astellas Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 84. Eisai Corporate Information, Location and Competitors Table 85. Eisai Anti-tumor Drug Major Business Table 86. Eisai Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 87. Eisai SWOT Analysis Table 88. Eisai Anti-tumor Drug Product and Solutions Table 89. Eisai Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 90. Bayer Corporate Information, Location and Competitors Table 91. Bayer Anti-tumor Drug Major Business Table 92. Bayer Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 93. Bayer SWOT Analysis Table 94. Bayer Anti-tumor Drug Product and Solutions Table 95. Bayer Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 96. Merck & Co Corporate Information, Location and Competitors Table 97. Merck & Co Anti-tumor Drug Major Business Table 98. Merck & Co Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 99. Merck & Co SWOT Analysis Table 100. Merck & Co Anti-tumor Drug Product and Solutions Table 101. Merck & Co Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 102. Teva Corporate Information, Location and Competitors Table 103. Teva Anti-tumor Drug Major Business Table 104. Teva Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 105. Teva SWOT Analysis Table 106. Teva Anti-tumor Drug Product and Solutions Table 107. Teva Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 108. Sanofi Anti-tumor Drug Type and Application Table 109. Sanofi Anti-tumor Drug Major Business Table 110. Sanofi Anti-tumor Drug Total Revenue (USD Million) (2017-2018) Table 111. Sanofi SWOT Analysis Table 112. Sanofi Anti-tumor Drug Product and Solutions Table 113. Sanofi Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019) Table 114. Global Anti-tumor Drug Revenue (Million USD) by Players (2015-2020) Table 115. Global Anti-tumor Drug Revenue Share by Players (2015-2020) Table 116. Global Anti-tumor Drug Revenue (Million USD) by Regions (2015-2020) Table 117. Global Anti-tumor Drug Revenue Market Share by Regions (2015-2020) Table 118. North America Anti-tumor Drug Revenue by Countries (2015-2020) Table 119. North America Anti-tumor Drug Revenue Market Share by Countries (2015-2020) Table 120. Europe Anti-tumor Drug Revenue (Million USD) by Countries (2015-2020) Table 121. Asia-Pacific Anti-tumor Drug Revenue (Million USD) by Countries (2015-2020) Table 122. South America Anti-tumor Drug Revenue by Countries (2015-2020) Table 123. South America Anti-tumor Drug Revenue Market Share by Countries (2015-2020) Table 124. Middle East and Africa Anti-tumor Drug Revenue (Million USD) by Countries (2015-2020) Table 125. Middle East and Africa Anti-tumor Drug Revenue Market Share by Countries (2015-2020) Table 126. Global Anti-tumor Drug Revenue (Million USD) by Type (2015-2020) Table 127. Global Anti-tumor Drug Revenue Share by Type (2015-2020) Table 128. Global Anti-tumor Drug Revenue Forecast by Type (2021-2025) Table 129. Global Anti-tumor Drug Revenue by Application (2015-2020) Table 130. Global Anti-tumor Drug Revenue Share by Application (2015-2020) Table 131. Global Anti-tumor Drug Revenue Forecast by Application (2021-2025) Table 132. Global Anti-tumor Drug Revenue (Million USD) Forecast by Regions (2021-2025) List of Figures Figure 1. Anti-tumor Drug Picture Figure 2. Global Anti-tumor Drug Revenue Market Share by Type in 2019 Figure 3. Cytotoxic Drugs Picture Figure 4. Non-cytotoxic Drugs Picture Figure 5. Anti-tumor Drug Revenue Market Share by Application in 2019 Figure 6. Alkylating Agents Picture Figure 7. Anti-metabolism Drugs Picture Figure 8. Platinum Antineoplastic Agents Picture Figure 9. Anthracycline antitumor drugs Picture Figure 10. Microtubule Stabilizer Picture Figure 11. Endocrine Therapy Drugs Picture Figure 12. Immunotherapy Drugs Picture Figure 13. Gene Therapy Drugs Picture Figure 14. Targeted Antineoplastic Drugs Picture Figure 15. Global Anti-tumor Drug Revenue (USD Million) and Growth Rate (2015-2025) Figure 16. North America Anti-tumor Drug Revenue (Million USD) and Growth Rate (2015-2025) Figure 17. Europe Anti-tumor Drug Revenue (Million USD) and Growth Rate (2015-2025) Figure 18. Asia-Pacific Anti-tumor Drug Revenue (Million USD) and Growth Rate (2015-2025) Figure 19. South America Anti-tumor Drug Revenue (Million USD) and Growth Rate (2015-2025) Figure 20. Middle East and Africa Anti-tumor Drug Revenue (Million USD) and Growth Rate (2015-2025) Figure 21. Global Anti-tumor Drug Revenue (Million USD) and Growth Rate (2015-2025) Figure 22. Global Anti-tumor Drug Revenue Share by Players in 2019 Figure 23. Global Top 5 Players Anti-tumor Drug Revenue Market Share in 2019 Figure 24. Global Top 10 Players Anti-tumor Drug Revenue Market Share in 2019 Figure 25. Key Players Market Share Trend Figure 26. Global Anti-tumor Drug Revenue (Million USD) and Growth Rate (%) (2015-2020) Figure 27. Global Anti-tumor Drug Revenue Market Share by Regions (2015-2020) Figure 28. Global Anti-tumor Drug Revenue Market Share by Regions in 2018 Figure 29. North America Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 30. Europe Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 31. Asia-Pacific Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 32. South America Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 33. Middle East and Africa Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 34. North America Anti-tumor Drug Revenue Market Share by Countries (2015-2020) Figure 35. North America Anti-tumor Drug Revenue Market Share by Countries in 2019 Figure 36. USA Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 37. Canada Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 38. Mexico Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 39. Europe Anti-tumor Drug Revenue Market Share by Countries (2015-2020) Figure 40. Europe Anti-tumor Drug Revenue Market Share by Countries in 2019 Figure 41. Germany Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 42. UK Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 43. France Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 44. Russia Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 45. Italy Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 46. Asia-Pacific Anti-tumor Drug Revenue Market Share by Countries (2015-2020) Figure 47. Asia-Pacific Anti-tumor Drug Revenue Market Share by Countries in 2019 Figure 48. China Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 49. Japan Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 50. Korea Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 51. India Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 52. Southeast Asia Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 53. South America Anti-tumor Drug Revenue Market Share by Countries (2015-2020) Figure 54. South America Anti-tumor Drug Revenue Market Share by Countries in 2019 Figure 55. Brazil Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 56. Argentina Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 57. Middle East and Africa Anti-tumor Drug Revenue Market Share by Countries (2015-2020) Figure 58. Middle East and Africa Anti-tumor Drug Revenue Market Share by Countries in 2019 Figure 59. Saudi Arabia Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 60. UAE Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 61. Egypt Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 62. South Africa Anti-tumor Drug Revenue and Growth Rate (2015-2020) Figure 63. Global Anti-tumor Drug Revenue Share by Type (2015-2020) Figure 64. Global Anti-tumor Drug Revenue Share by Type in 2019 Figure 65. Global Anti-tumor Drug Market Share Forecast by Type (2021-2025) Figure 66. Global Cytotoxic Drugs Revenue Growth Rate (2015-2020) Figure 67. Global Non-cytotoxic Drugs Revenue Growth Rate (2015-2020) Figure 68. Global Anti-tumor Drug Revenue Share by Application (2015-2020) Figure 69. Global Anti-tumor Drug Revenue Share by Application in 2019 Figure 70. Global Anti-tumor Drug Market Share Forecast by Application (2021-2025) Figure 71. Global Alkylating Agents Revenue Growth Rate (2015-2020) Figure 72. Global Anti-metabolism Drugs Revenue Growth Rate (2015-2020) Figure 73. Global Platinum Antineoplastic Agents Revenue Growth Rate (2015-2020) Figure 74. Global Anthracycline antitumor drugs Revenue Growth Rate (2015-2020) Figure 75. Global Microtubule Stabilizer Revenue Growth Rate (2015-2020) Figure 76. Global Endocrine Therapy Drugs Revenue Growth Rate (2015-2020) Figure 77. Global Immunotherapy Drugs Revenue Growth Rate (2015-2020) Figure 78. Global Gene Therapy Drugs Revenue Growth Rate (2015-2020) Figure 79. Global Targeted Antineoplastic Drugs Revenue Growth Rate (2015-2020) Figure 80. Global Anti-tumor Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025) Figure 81. Global Anti-tumor Drug Revenue (Million USD) Forecast by Regions (2021-2025) Figure 82. Global Anti-tumor Drug Revenue Market Share Forecast by Regions (2021-2025) Figure 83. North America Anti-tumor Drug Revenue Market Forecast (2021-2025) Figure 84. Europe Anti-tumor Drug Revenue Market Forecast (2021-2025) Figure 85. Asia-Pacific Anti-tumor Drug Revenue Market Forecast (2021-2025) Figure 86. South America Anti-tumor Drug Revenue Market Forecast (2021-2025) Figure 87. Middle East and Africa Anti-tumor Drug Revenue Market Forecast (2021-2025) Figure 88. Sales Channel: Direct Channel vs Indirect Channel

Roche Takeda Bristol-Myers Squibb Novartis Pfizer Celgene AstraZeneca Johnson & Johnson Amgen Eli Lilly Biogen Idec Otsuka Astellas Eisai Bayer Merck & Co Teva Sanofi